RSS FeedDexCom, Inc. Stock Moving Up DXCM
Shares of DexCom (NASDAQ:DXCM) traded at a new 52-week high today of $13.71. Approximately 162,000 shares have traded hands today vs. average 30-day volume of 351,000 shares.
DexCom (DXCM), has a new continuous glucose management product for diabetics to use at home that is growing significantly, more than doubling in revenues over the last year, and the stock is up over 300% since early 2009.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver.
0 Comments
You can be the first one to leave a comment.